Intranasal Dexmedetomidine
Cross-source consensus on Intranasal Dexmedetomidine from 1 sources and 6 claims.
1 sources · 6 claims
Uses
Benefits
Comparisons
Evidence quality
Highlighted claims
- Intranasal dexmedetomidine is being evaluated as a perioperative treatment for sleep disturbance. — Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis
- Intranasal delivery avoids venipuncture and intramuscular injection pain. — Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis
- Intranasal dexmedetomidine has practical administration advantages including high bioavailability, simplicity, convenience, and no mucosal irritation. — Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis
- Evidence for intranasal dexmedetomidine remains uncertain because existing studies are small, diverse, and inconsistent in quality. — Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis
- Intranasal dexmedetomidine has a slower onset and a more favorable cardiovascular safety profile than IV bolus administration. — Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis
- Intranasal dexmedetomidine has shown benefits for anxiety-related insomnia, chronic insomnia, pediatric refractory sleep disturbance, and sleep disorders in elderly general anesthesia patients. — Intranasal dexmedetomidine for perioperative sleep disturbance: a protocol for a systematic review with meta-analysis and trial sequential analysis